Skip to content
Open access

Interpretable gene networks from single-cell foundation models reveal conserved neurogenic dysfunction in Parkinson’s disease

Jul 2026 · bioRxiv · 0 citations · 16 references
Biology

Abstract

Interpreting large-scale single-cell transcriptomic data remains a major challenge for understanding disease mechanisms. Recent single-cell foundation models learn rich representations of gene relationships across millions of cells, yet methods for translating these embeddings into biologically interpretable gene networks remain limited. Here we present scGENet, a computational framework that constructs context-specific gene interaction networks from foundation model–derived gene embeddings. By fine-tuning pretrained models on transcriptomic data from human midbrain organoids, scGENet generates transcriptome-scale gene modules that capture biologically meaningful cellular programs. Benchmarking across multiple foundation models demonstrates that networks derived from a fine-tuned scGPT brain model show the highest concordance with curated neuronal pathways, Parkinson’s disease (PD) genetic risk loci, and independent patient-derived transcriptional signatures. Applying this framework to human iPSC-derived PD midbrain organoids reveals transcriptional modules associated with neuronal differentiation, synaptic signaling, and cell-cycle regulation. Single-nucleus RNA sequencing further links these programs to altered cellular composition, including reduced dopaminergic neurons, expansion of radial glia–like progenitors, and a dopaminergic neuron subtype expressing SNCA and VGLUT2. Integration with independent human substantia nigra datasets identifies a conserved neurogenic program disrupted across genetic and idiopathic PD. Together, these results establish a generalizable strategy for extracting interpretable gene networks from single-cell foundation models, enabling systematic discovery of disease-relevant molecular programs across diverse tissues and datasets.

Read PDF

Similar papers

#graph neural networks Open access Sep 2026

Personalized single-cell transcriptomics reveals molecular diversity in Alzheimer’s disease

A personalized functional genomics atlas for Alzheimer’s disease that uses knowledge-guided graph neural networks to analyze donor-level functional genomics, identify disease subpopulations and trajectories, and link genetic variants to gene regulation is summarized.

P. Chandrashekar, S. Alatkar, Noah Cohen Kalafut et al. · 1 citation
Open access Aug 2026

Coordinated dysregulation of modular gene activity in human neuropathologies

By comparing CoPA projection patterns between normal and pathological human brain samples using differential CoPA, this work identifies gene coexpression modules that are uniformly and reproducibly dysregulated in specific neocortical cell types in Alzheimer’s disease or schizophrenia.

Gugene Kang, M. C. Oldham · 0 citations
Open access Nov 2024

Single-nucleus transcriptome-wide association study of human brain disorders

These findings provide a cell-type-resolved and ancestry-aware atlas of genetically regulated expression in the human prefrontal cortex and illustrate how single-nucleus transcriptomics can sharpen gene discovery and therapeutic target prioritization for complex brain disorders.

S. Venkatesh, Roman Kosoy, Zhen-Yi Wu et al. · 7 citations
Sep 2026

Mapping cell-type- and age-dependent neuronal vulnerability through genome-wide in vivo CRISPRi screens in the mouse brain.

A scalable, cell-type-resolved in vivo CRISPR interference (CRISPRi) platform enabling systematic gene function profiling in the mouse brain is developed and the CRISPRinvivo data portal is established as a community resource for in vivo screening.

Risheng Lin, Ze-Ting Ke, Jian-Hui Wang et al. · 0 citations
Review Aug 2026

EXPRESS: Harnessing Single-Cell Gene Regulatory Networks for Precision Health.

This manuscript explores the current landscape of single-cell RNA sequencing (scRNA-seq), highlighting key studies that have leveraged this technology to advance biological understanding for clinical purposes through the construction of gene regulatory networks (GRNs) from single-cell transcriptomic data.

J. López-Castiblanco, L. López-Kleine, Yesid Cuesta-Astroz · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.